CS271293B1 - Mouse lymphocyte hybridoma vu t51/3 - Google Patents

Mouse lymphocyte hybridoma vu t51/3 Download PDF

Info

Publication number
CS271293B1
CS271293B1 CS888157A CS815788A CS271293B1 CS 271293 B1 CS271293 B1 CS 271293B1 CS 888157 A CS888157 A CS 888157A CS 815788 A CS815788 A CS 815788A CS 271293 B1 CS271293 B1 CS 271293B1
Authority
CS
Czechoslovakia
Prior art keywords
hybridoma
type
herpes simplex
monoclonal antibody
virus
Prior art date
Application number
CS888157A
Other languages
Czech (cs)
Slovak (sk)
Other versions
CS815788A1 (en
Inventor
Magdalena Ing Csc Bystricka
Miriam Rndr Vancikova
Marta Rndr Kasalova
Gustav Rndr Csc Russ
Pavol Mvdr Csc Ragac
Marta Rndr Miklosova
Original Assignee
Bystricka Magdalena
Vancikova Miriam
Kasalova Marta
Russ Gustav
Ragac Pavol
Miklosova Marta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bystricka Magdalena, Vancikova Miriam, Kasalova Marta, Russ Gustav, Ragac Pavol, Miklosova Marta filed Critical Bystricka Magdalena
Priority to CS888157A priority Critical patent/CS271293B1/en
Publication of CS815788A1 publication Critical patent/CS815788A1/en
Publication of CS271293B1 publication Critical patent/CS271293B1/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The solution applies to the murine lymphocytic hybridoma that produces the monoclonal antibody against the virus Herpea simplex type 1 and is stored in the collection of hybridomas of the Institute of virology SAV in Bratislava under the title V' T51/3.The monoclonal antibody produced by the hybridoma V' T51/3 is suitable for diagnostic purposes in the immunofluorescent test (IF), in the radio-immunoassay test (RIA) and in the immunoenzymatic analysis (ELISA) for the determination of the presence and the amount of viral antigen in the tested material.

Description

Vynález sa týká nového hybridómu, t»j· hybridného jednobunkového organizmu, zostrojeného fúziou myšej myelómovej buňky Sp2/O a myše) slezinovej lymfoidnej buňky, produkujúcej protilátku voči virusu Herpes simplex typ 1.The invention relates to a novel hybridoma, i.e. a hybrid one-cell organism constructed by fusing a mouse myeloma cell Sp2 / O and a mouse spleen lymphoid cell producing an antibody to Herpes simplex virus type 1.

U virusu Herpes simplex rozoznávame dva antigénne odlišné typy Herpes simplex typ 1 a typ 2« Doteraz sa protilátky (antiséra) voči virusu Herpes simplex typ 1 připravovali imunizáciou pokusných zvierat, najčastejšie králikov, purifikovaným alebo nepurifikovaným vírusom resp· niektorým izolovaným proteínom /Forghani B., Schmidt N., Lennette E. H·: Solid phase rádioimmunoassay for identitication of herpesvirus hominis types 1 and 2 from clinical materiál· Appl. Microbiol· 28, /1974/ 661 - 667* Dreesman G. R., Watson 0. 0., Courtney R. □·, Adam E·, Melnick □· L.: Oetection of herpesvirus type- 4 In Herpes simplex virus, we recognize two antigenically different types of Herpes simplex type 1 and type 2. , Schmidt N., Lennette E. H: Solid phase radioimmunoassay for identification of herpesvirus hominis types 1 and 2 from clinical material Appl. Microbiol · 28, / 1974/661 - 667 * Dreesman GR, Watson 0. 0, Courtney R. Adam, Adam E Mel, Melnick L L .: Oetection of herpesvirus type- 4

-specific antibody by microsolid-phase radioimmunometric assay* Intervirology 12, /1979/ 115 - 119)· Sérum takto imunizovaných zvierat, odobrané po viacerých dávkách antigénu, slúžilo ako zdroj protilátok tzv· typovošpecifických, ktoré sa využívali na dokaž antigénu virusu Herpes simplex typ 1 v základnom výskume a v imunodiagnostickej praxi· Vzhladom na to, že virusy Herpes simplex typ 1 a 2 obsahujú nielen typovošpecifické, ale aj typovo spoločné antigénne determinanty, takto připravené antiséra voči virusu Herpes simplex obsahujú vysoké hladiny typovospoločných protilátok, ktoré slažujú resp· úplné znemožňujú správné určenie typu infikujúceho virusu pri diagnostickom testovaní· TypovospoloČné protilátky sa obvykle odstranujú zo sér vysycovánim s vírusom Herpes simplex typ 2, čo je procedúra velmi náročná na materiál a naviac len v malom počte prípadov úspěšná· Výrobné šarže konvenčných typovošpecifických antisér sa dajú lažko Standardizoval a bývajú v Sirokom rozmedzi kvality· V poslednom čase sa s úspěch om používájú na typizáciu virusu Herpes simplex typ 1 monoklonálne protilátky tzv· typovošpecifické, ktoré sú schopné detegoval infekciu vírusom Herpes simplex typ 1 v кliniekom materiále·The serum of such immunized animals, taken after multiple doses of antigen, served as a source of so-called type-specific antibodies which were used to prove the Herpes simplex virus type antigen. · Since Herpes simplex viruses type 1 and 2 contain not only type-specific, but also type-common antigenic determinants, the herpes simplex virus antisera thus prepared contain high levels of type-common antibodies that reduce or prevent completely Correctly identifying the type of infecting virus in diagnostic testing · Type-common antibodies are usually removed from Herpes simplex type 2 virus sera, which is a very material-intensive procedure and, in a small number of cases, successful · Production batches of conventional typespecific h Antisera are easy to standardize and live in a wide quality range · Recently, monoclonal antibodies, so-called type-specific monoclonal antibodies that are capable of detecting Herpes simplex type 1 virus infection, have been successfully used to clone the virus.

Uvedené nevýhody doteraz používaných postupov sa nevyskytnú, ak je к dispozic i i hybridómova banková línia produkujúca typovošpecifickú monoklonálnu protilátku voči virusu Herpes simplex typ 1, ktorá Je uložená v zbierke hybridómov Virologického ústavu SAV, Mlýnská dolina 1, Bratislava pod označením VÚ T51/3.The above disadvantages of the methods used so far do not occur if there is also a hybridoma bank line producing a type-specific monoclonal antibody against Herpes simplex virus type 1, which is stored in the collection of hybrids of the Institute of Virology of the Slovak Academy of Sciences, Mlýnská dolina 1, Bratislava.

Uvedený hybridám bol získaný spósobom známým z odbornej literatúry (Kohler, G·, Milstein, C·; Continuous cultures of fused cells secreting antibody of predefined specifity· Nátur, 256 /1975/, 495·, Gerhard, W.: Fusion of cells in suspension and outgrowth of hybride in conditioned medium· Monoclonal antibodies: A new dimension in Biological analyses· Kennett R· H. a spol·, eds New York, plenům Press /1980/, 37C)· Hybridné buňky získané po fúzi i myších myelómových Sp2/0 buniek a buniek získaných zo sleziny myši BALB/c imunizované) extraktom buniek infikovaných vírusom Herpes simplex typ 1, bol i klonované, a po otestovaní bol vybraný klon VÚ T51/3· Výhodou hybridómu je, že produkuje homogénnu protilátku, tzv. monoklonálnu protilátku, ktorá Je schopná Specificky reagoval 8 vírusom Herpes simplex typ 1. Hybridám vil T51/3 možno kultivoval in vitro v médiach vhodných pre živočišné buňky alebo in vivo v perritoneálnej dutině myši kmeňa BALB/c· Z konzerv zmrazených buniek uchovaných v kvapalnom dusíku, možno začal produkciu protilátky bez óalŠej imunizácie zvierala antigénom· , i Příklad:The hybrids were obtained in a manner known from the literature (Kohler, G, Milstein, C; Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity, Nature, 256 (1975), 495), Gerhard, W., Fusion of Cells in · Monoclonal antibodies: A new dimension in Biological analyzes · Kennett R.H. et al., eds New York, Diapers Press (1980), 37C) · Hybrid cells obtained after fusion of murine myeloma Sp2 (0 cells and cells obtained from the spleen of BALB (c mice immunized) with an extract of cells infected with Herpes simplex virus type 1, were also cloned, and after testing a clone of TU T51 / 3 was selected. a monoclonal antibody capable of specifically reacting with Herpes simplex virus type 8 virus. T51 / 3 hybrid hybrids can be cultured in vitro in animal cell media or in vivo in the perritoneal cavity of a BALB / c mouse. From canned frozen cells stored in liquid nitrogen , the production of an antibody without further immunization with an antigen may have begun.

Za účelom získania váčšieho množstva monoklonálnej protilátky νΰ T51/3 kultiváciou hybridómov buniek in vivo, 5xl06 buniek sa aplikovalo do peritoneálnej dutiny myší. Pre lepSie uchytenie buniek bola myš 15 dní před aplikáciou buniek premedikovaná parafínovým olejom /0,5 ml antraperitoneálne na 1 myš/, po 10 dnoch rastu hybridómu v peritoneálnej dutině, bola myš zabitá a vyprodukovaná ascitická tekutina odobraná. Týmto postupom možno priemerne získat asi 7 ml ascitickej tekutiny obsahujúcej 8 mg/ml protilátky. Ascitická tekutina obsahujúca produkt hybridómu VÚ T51/3 vykazovala Specifická vazbu к virusu Herpes simplex typ 1 v rádioimunoanalytickom teste /RIA/, v imunoenzymatickej analýze /ELISA/ a v imunofluorescenčnom teste /IF/.In order to obtain a greater amount of monoclonal antibody ν51 T51 / 3 by culturing hybridomas of cells in vivo, 5x10 6 cells were injected into the peritoneal cavity of mice. For better cell attachment, mice were pre-treated with paraffin oil (0.5 ml anthraperitoneally per mouse) 15 days prior to cell application, after 10 days of hybridoma growth in the peritoneal cavity, the mouse was killed and the ascites fluid produced was collected. On average, about 7 ml of ascites fluid containing 8 mg / ml antibody is obtained by this procedure. The ascites fluid containing the hybridoma product T51 / 3 showed specific binding to Herpes simplex virus type 1 in the radioimmunoassay (RIA), immunoenzymatic assay (ELISA) and immunofluorescence assay (IF).

CS 271293 8181

Buňky hybridómu VÚ T51/3 rastů in vitro ako polosuspenzná kultúra. Majů gulatý tvar a velkost charakteristická pre myelómove buňky· Obsahujú fúzované buňkové jadrá, sú aneuploídne· Buňky hybridómu VÚ T51/3 majú ultraštruktúrny obraz typických myelomových buniek, kde prevažujúcou organelou su volné a na membránu viazané polyribozómy. Základným kultivačným médiom je Dulbeccova modifikacia Eagleovho minimálneho esenciólneho média (Dulbecco, R., Freeman, G., Virology 8/1959/, 396). Toto médium, označované ako OMEM, je pre kultiváciu hybridómu doplněné gentamycínom a inaktivovaným prekolostrálnym telecím sérom (10%, Bioveta, Ivanovice na Hané)· Hybridóm je kultivovaný pri 37 °C v atmosféře 5% CO^· 3eho generačně doba je přibližné 24 h· produkovaná protilátka je monoklonály imunoglobín podtriedy igG 2b·In vitro hybridoma cells of T51 / 3 growth as a semi-suspension culture. They have a round shape and size characteristic of myeloma cells. They contain fused cell nuclei, are aneuploid. The basic culture medium is Dulbecco's modification of Eagle's minimal essential medium (Dulbecco, R., Freeman, G., Virology 8 (1959), 396). This medium, called OMEM is the cultivation of the hybridoma supplemented with gentamicin and inactivated precolostral calf serum (10%, Bioveta Ivanovice na Hane) · The hybridoma was cultured at 37 ° C in 5% CO ^ · 3 eho of recent time is about 24 h · the antibody produced is immunoglobin monoclonals of subclass igG 2b ·

Hybridóm VÚ T51/3 može byt využívaný ako zdroj protilátky voči virusu Herpes simplex typ 1, ktorá sa da použit na kvalitatívny dokaž přítomnosti virusu Herpes simplex typ 1 vo vyšetrovanom materiále, na kvantitativné stanovenie množstva infikujúceho virusu, pri vyhodnocovaní epidemiologickéj situácie a ako zdroj protilátky jedinej podtriedy (igG 2b) pre přípravu antisér Specifických pre uvedená podtriedu.The T51 / 3 hybridoma can be used as a source of antibody to Herpes simplex virus type 1, which can be used to qualitatively prove the presence of Herpes simplex virus type 1 in the material under investigation, quantitatively determining the amount of infecting virus, assessing the epidemiological situation and a single subclass (igG 2b) for preparing antisera specific for said subclass.

Claims (2)

Myší lymfocytárny hybridóm VÚ T51/3, produkujúci monoklonálnu protilátku podtriedy igG 2b voči virusu Herpes simplex typ 1.Murine lymphocyte hybridoma TU / T51 / 3, producing a monoclonal antibody of subclass igG 2b against Herpes simplex virus type 1.
CS888157A 1988-12-09 1988-12-09 Mouse lymphocyte hybridoma vu t51/3 CS271293B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS888157A CS271293B1 (en) 1988-12-09 1988-12-09 Mouse lymphocyte hybridoma vu t51/3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS888157A CS271293B1 (en) 1988-12-09 1988-12-09 Mouse lymphocyte hybridoma vu t51/3

Publications (2)

Publication Number Publication Date
CS815788A1 CS815788A1 (en) 1989-11-14
CS271293B1 true CS271293B1 (en) 1990-09-12

Family

ID=5431777

Family Applications (1)

Application Number Title Priority Date Filing Date
CS888157A CS271293B1 (en) 1988-12-09 1988-12-09 Mouse lymphocyte hybridoma vu t51/3

Country Status (1)

Country Link
CS (1) CS271293B1 (en)

Also Published As

Publication number Publication date
CS815788A1 (en) 1989-11-14

Similar Documents

Publication Publication Date Title
Lee et al. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens.
Yamashita et al. Prevalence of newly isolated, cytopathic small round virus (Aichi strain) in Japan
EP0162533A2 (en) The detection of human cytomegalovirus specific IgM
Ferguson et al. Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3
CN112760294A (en) Canine type I adenovirus monoclonal antibody/polyclonal antibody, double-antibody sandwich ELISA kit and application
Nixon et al. Serological comparisons of antigenically related herpesviruses in cattle, red deer and goats
US4752582A (en) Monoclonal antibodies to human glycophorin A and cell lines for the production thereof
Park et al. Evaluation of an indirect fluorescent IgM antibody test for the detection of pigs with recent infection of porcine reproductive and respiratory syndrome virus
Torfason et al. Indirect and reverse radioimmunoassays and their apparent specificities in the detection of antibodies to enteroviruses in human sera
EP0100955A2 (en) Monoclonal immunoglobulin M antibodies and method of preparation
Lenkei et al. High correlations of anti-CMV titers with lymphocyte activation status and CD57 antibody-binding capacity as estimated with three-color, quantitative flow cytometry in blood donors
US5130232A (en) Monoclonal antibody immunoassay kit for avian reticuloendotheliosis virus
Flaegstad et al. Neutralization test for BK virus: plaque reduction detected by immunoperoxidase staining
CS271293B1 (en) Mouse lymphocyte hybridoma vu t51/3
Kao et al. Monoclonal antibodies for the rapid diagnosis of respiratory syncytial virus infection by immunofluorescence
CN114656552A (en) Monoclonal antibody against Marek's virus, hybridoma cell strain thereof and application of detection kit
CS270194B1 (en) Mouse lymphocyte hybridoma vu 499/1
Dawson et al. Monoclonal antibodies to hepatitis A virus
US4572896A (en) Monoclonal antibodies to herpes simplex virus type I polypeptides
CS270195B1 (en) Mouse lymphocyte hybridoma vu 809/5
CS271292B1 (en) Mouse lymphocyte hybridoma vu 440/2
CN110607282A (en) Bovine parvovirus monoclonal antibody and application thereof in detecting bovine parvovirus infection
US7993647B2 (en) Monoclonal antibodies to HIV-1 and methods of using same
CN105319361B (en) Scylla paramamosain reovirus colloidal gold immunochromatographimethod reagent strip and preparation method thereof, application method
US20030044849A1 (en) Methods for screening monoclonal antibodies on heterogeneous antigen substrates